The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.
UOM: Pallet (20 tests/box, 32 boxes/cs, 20 cases per pallet)
Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.
Product Features:
- Lateral flow assay
- Rapid results in 10 minutes
- Anterior nare (nasal) specimen collection
- Intended at POC setting (i.e., in patient care settings) by medical professionals with a CLIA waiver
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Identify acute infection with 87.2% sensitivity and 100% specificity
- Storage condition: 1-30 degrees celsius
Specifications
| Test type | Lateral flow immunochromatographic assay |
| Specimen type | Anterior nasal (AN) |
| Turnaround time | 10 minutes |
| CLIA complexity | Waived, Moderate, or High complexity |
| FDA status | Emergency Use Authorization (EUA) granted |
| Packaging |
20 tests/box, 32 boxes/cs, 20 cases per pallet |
Resources
The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.
UOM: Pallet (20 tests/box, 32 boxes/cs, 20 cases per pallet)
Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.
Product Features:
- Lateral flow assay
- Rapid results in 10 minutes
- Anterior nare (nasal) specimen collection
- Intended at POC setting (i.e., in patient care settings) by medical professionals with a CLIA waiver
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Identify acute infection with 87.2% sensitivity and 100% specificity
- Storage condition: 1-30 degrees celsius
Specifications
| Test type | Lateral flow immunochromatographic assay |
| Specimen type | Anterior nasal (AN) |
| Turnaround time | 10 minutes |
| CLIA complexity | Waived, Moderate, or High complexity |
| FDA status | Emergency Use Authorization (EUA) granted |
| Packaging |
20 tests/box, 32 boxes/cs, 20 cases per pallet |
Resources
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests Price List
| Store | Price | ||
|---|---|---|---|